Literature DB >> 31686747

Performance of Common Down Syndrome Screening Methods Used in India with Construction of an Indian Normogram for Nuchal Translucency/Crown-Rump Length Measurements in 14,337 Subjects.

Anita Kaul1, Prathima Radhakrishnan2.   

Abstract

BACKGROUND/PURPOSE OF STUDY: Sonologists often lack access to the Fetal Medicine Foundation Down syndrome risk calculation software or cannot offer the combined test for aneuploidy screening because of resource constraints. Instead, sonologists use nuchal translucency (NT) measurements that rely on fixed NT cut-offs for labelling foetuses with high risks for Down syndrome. In the present study, we aimed to plot normative data for NT and the crown-rump length (CRL) in Indian foetuses and to assess the value of using the 95th/99th centiles of NT for CRL cut-offs instead of fixed NT cut-offs to calculate the risk for aneuploidies during the first trimester.
METHODS: We conducted a retrospective observational study measuring the NT/CRL in 14,337 Indian foetuses between 11 and 13 + 6 weeks of gestation. We used regression analysis and calculated the 95th/99th centiles of NT distribution. We compared performances of NT > 95th/99th centiles and fixed NT cut-offs of 2.5- and 3.5-mm  as screening.
RESULTS: The NT measurements increased with increasing CRL values. NT > 95th centile for a particular CRL for detecting all aneuploidies had the maximum sensitivity of 73.9% for a false positive rate (FPR) of 4.3%. Similar values for fixed cut-off > 2.5 mm were 63.0% FPR 3.7% (T21 68.2 FPR 3.8%) and for NT > 3.5 mm 36.9% FPR 0.43% (T21 36.5% FPR 0.5%).
CONCLUSION: A fixed NT cut-off point is not appropriate for the first trimester screening. The best sensitivity for assessing aneuploidies is achieved using the 95th centile, but the 99th centile achieves higher specificity for gestational age. © Federation of Obstetric & Gynecological Societies of India 2019.

Entities:  

Keywords:  Antenatal screening; Combined first trimester screening; Down syndrome; NT normogram; Nuchal translucency

Year:  2019        PMID: 31686747      PMCID: PMC6801244          DOI: 10.1007/s13224-018-1196-3

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  15 in total

1.  Prospective audit of a one-centre combined nuchal translucency and triple test programme for the detection of trisomy 21.

Authors:  Vijayalakshmi Babbur; Christoph C Lees; Sandra F Goodburn; Nigel Morris; Andrew C G Breeze; Gerald A Hackett
Journal:  Prenat Diagn       Date:  2005-06       Impact factor: 3.050

2.  Outcome of fetuses with enlarged nuchal translucency and normal karyotype.

Authors:  C M Bilardo; E Pajkrt; I de Graaf; B W Mol; O P Bleker
Journal:  Ultrasound Obstet Gynecol       Date:  1998-06       Impact factor: 7.299

3.  Observational study comparing the performance of first-trimester screening protocols for detecting trisomy 21 in a North Indian population.

Authors:  Anita Kaul; Chanchal Singh; Rachna Gupta; Nidhi Arora; Abha Gupta
Journal:  Int J Gynaecol Obstet       Date:  2017-01-20       Impact factor: 3.561

4.  Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women.

Authors:  E Hafner; K Schuchter; E Liebhart; K Philipp
Journal:  Prenat Diagn       Date:  1998-01       Impact factor: 3.050

5.  Intellectual disability in Indian children: experience with a stratified approach for etiological diagnosis.

Authors:  Silky Jain; Veena Chowdhury; Monica Juneja; Madhulika Kabra; Sanjeev Pandey; Ankur Singh; Malobika Bhattacharya; Seema Kapoor
Journal:  Indian Pediatr       Date:  2013-06-05       Impact factor: 1.411

6.  The first trimester 'combined test' for the detection of Down syndrome pregnancies in 4939 unselected pregnancies.

Authors:  K Schuchter; E Hafner; G Stangl; M Metzenbauer; D Höfinger; K Philipp
Journal:  Prenat Diagn       Date:  2002-03       Impact factor: 3.050

7.  The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down's syndrome.

Authors:  G D Michailidis; K Spencer; D L Economides
Journal:  BJOG       Date:  2001-10       Impact factor: 6.531

8.  Nuchal translucency: an ultrasound marker for fetal chromosomal abnormalities.

Authors:  G L Acácio; R Barini; W Pinto Júnior; R L Ximenes; H Pettersen; M Faria
Journal:  Sao Paulo Med J       Date:  2001-01-04       Impact factor: 1.044

9.  Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.

Authors:  E Pajkrt; B W Mol; J M van Lith; O P Bleker; C M Bilardo
Journal:  Ultrasound Obstet Gynecol       Date:  1998-09       Impact factor: 7.299

10.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

Authors:  K H Nicolaides; G Azar; D Byrne; C Mansur; K Marks
Journal:  BMJ       Date:  1992-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.